Cellectar Biosciences, Inc. (CLRB)
3.31
+0.17
(+5.41%)
USD |
NASDAQ |
Feb 13, 14:15
Cellectar Biosciences Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Imunon, Inc. | 0.00 |
| PDS Biotechnology Corp. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Savara, Inc. | 21.47M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.275M |
| Cash from Financing (Quarterly) | 5.788M |
| Free Cash Flow | -29.75M |
| Free Cash Flow Per Share (Quarterly) | -1.352 |
| Free Cash Flow to Equity (Quarterly) | -4.254M |
| Free Cash Flow to Firm (Quarterly) | -4.275M |
| Free Cash Flow Yield | -37.09% |